Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
14.75
-2.71 (-15.52%)
At close: Dec 5, 2025, 4:00 PM EST
14.79
+0.04 (0.27%)
After-hours: Dec 5, 2025, 7:58 PM EST
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of $2.25 billion as of December 5, 2025. Its market cap has increased by 240.59% in one year.
Market Cap
2.25B
Enterprise Value
2.25B
1-Year Change
240.59%
Ranking
Category
Stock Price
$14.75
Market Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.77B to $2.25B, a decrease of -52.84%. That is a compound annual growth rate of -11.00%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |